FDA Shortages Nov 27, 2021

FDA Drug Shortages 11-7-21

FDA Investigating Certain Imported Medical Gloves

FDA Drug Shortages - Oct 2021

FDA Shortages September/October 2021

Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency

Recall- AMSORB PLUS PREFILLED G-CAN 1.0L Due to Reduced Gas Flow to Patients During Anesthesia

Voluntary Nationwide Recall of Cefazolin Injection Products Due to a Lack of Sterility Assurance

Schizophrenia Diagnosis in Nursing Homes Has Increased Significantly Since 2012

Teligent Pharma Voluntary Recall Lidocain Topical 4%

FDA Shortages August 2021

Select Monoject Flush Prefilled Saline Syringes By Cardinal Health: Recall

Sodium Bicarb in 5% Dextrose Inj 150 mEq per 1,000 mL by SterRx: Recall - Due to Microbial Contamin

Specific NEUTROGENA and AVEENO Aerosol Sunscreen Products by Johnson & Johnson: Recall

Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Statins

FDA Drug Shortages

Twelve Lot of CHANTIX (Varenicline) Tablets by Pfizer: Recall - Due to N-Nitroso Varenicline Content

Surgical Procedure Packs by DeRoyal Industries: Class I Recall - Due to Mislabeled Lidocaine

Viona Pharmaceuticals Voluntary Recall of Metformin ER

FDA Restricts Use of Ocaliva in Primary Biliary Cholangitis Patients with Advanced Cirrhosis